Graybug Vision, Inc. GRAY Stock
Graybug Vision, Inc. Price Chart
Graybug Vision, Inc. GRAY Financial and Trading Overview
| Graybug Vision, Inc. stock price | 5.5 USD |
| Previous Close | 6.17 USD |
| Open | 5.55 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 1000 |
| Day's Range | 5.02 - 6 USD |
| 52 Week Range | 0.45 - 10.62 USD |
| Volume | 24.63K USD |
| Avg. Volume | 7.47K USD |
| Market Cap | 120.98M USD |
| Beta (5Y Monthly) | 1.199174 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 49 USD |
GRAY Valuation Measures
| Enterprise Value | 96.7M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.3132532 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.3172498 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.941 |
Trading Information
Graybug Vision, Inc. Stock Price History
| Beta (5Y Monthly) | 1.199174 |
| 52-Week Change | 200.85% |
| S&P500 52-Week Change | 6.37% |
| 52 Week High | 10.62 USD |
| 52 Week Low | 0.45 USD |
| 50-Day Moving Average | 7.94 USD |
| 200-Day Moving Average | 3.3 USD |
GRAY Share Statistics
| Avg. Volume (3 month) | 7.47K USD |
| Avg. Daily Volume (10-Days) | 34.55K USD |
| Shares Outstanding | 22M |
| Float | 10.32M |
| Short Ratio | 0.91 |
| % Held by Insiders | 2.58% |
| % Held by Institutions | 54.52% |
| Shares Short | 20.16K |
| Short % of Float | 0.16% |
| Short % of Shares Outstanding | 0.090% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:14 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -38.17% |
| Return on Equity (ttm) | -70.50% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -32879000 USD |
| Net Income Avi to Common (ttm) | -35605000 USD |
| Diluted EPS (ttm) | -20.63 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 39.13M USD |
| Total Cash Per Share (mrq) | 1.78 USD |
| Total Debt (mrq) | 203K USD |
| Total Debt/Equity (mrq) | 0.56 USD |
| Current Ratio (mrq) | 10.725 |
| Book Value Per Share (mrq) | 1.658 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -22879000 USD |
| Levered Free Cash Flow (ttm) | -13656625 USD |
Profile of Graybug Vision, Inc.
| Country | United States |
| State | CA |
| City | Redwood City |
| Address | 203 Redwood Shores Parkway |
| ZIP | 94065 |
| Phone | 650 487 2800 |
| Website | https://www.graybug.vision |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.
Q&A For Graybug Vision, Inc. Stock
What is a current GRAY stock price?
Graybug Vision, Inc. GRAY stock price today per share is 5.5 USD.
How to purchase Graybug Vision, Inc. stock?
You can buy GRAY shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Graybug Vision, Inc.?
The stock symbol or ticker of Graybug Vision, Inc. is GRAY.
Which industry does the Graybug Vision, Inc. company belong to?
The Graybug Vision, Inc. industry is Biotechnology.
How many shares does Graybug Vision, Inc. have in circulation?
The max supply of Graybug Vision, Inc. shares is 21.56M.
What is Graybug Vision, Inc. Price to Earnings Ratio (PE Ratio)?
Graybug Vision, Inc. PE Ratio is 0.00000000 now.
What was Graybug Vision, Inc. earnings per share over the trailing 12 months (TTM)?
Graybug Vision, Inc. EPS is 0 USD over the trailing 12 months.
Which sector does the Graybug Vision, Inc. company belong to?
The Graybug Vision, Inc. sector is Healthcare.
Graybug Vision, Inc. GRAY included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}